Jason Dinges

Jason Dinges is an experienced investment professional and intellectual property counsel at Morningside Technology Advisory LLC since February 2011. In addition to this role, Jason serves on the board of several companies, including Geneoscopy, Vesigen Therapeutics, Alentis Therapeutics, Prilenia, Intellihealth, Inotrem SA, ZielBio, Inc., IM Therapeutics, and Adiso Therapeutics. Jason's academic background includes a J.D. from the University of Iowa College of Law, a Ph.D. in Genetics from Iowa State University, and a B.S. in Biology from Illinois Wesleyan University.